ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257,862,440 | -20.4% | 7,233,168 | +3.1% | 0.01% | -25.0% |
| Q2 2023 | $323,763,497 | +19.6% | 7,018,502 | +3.9% | 0.01% | +14.3% |
| Q1 2023 | $270,808,413 | -8.3% | 6,753,327 | +5.9% | 0.01% | -12.5% |
| Q4 2022 | $295,318,075 | +15.7% | 6,374,230 | +3.4% | 0.01% | 0.0% |
| Q3 2022 | $255,163,000 | -30.3% | 6,161,866 | +0.5% | 0.01% | -20.0% |
| Q2 2022 | $365,963,000 | -15.5% | 6,134,144 | +2.9% | 0.01% | 0.0% |
| Q1 2022 | $433,060,000 | -13.0% | 5,963,374 | +0.7% | 0.01% | -9.1% |
| Q4 2021 | $497,860,000 | -6.0% | 5,920,568 | +0.8% | 0.01% | -15.4% |
| Q3 2021 | $529,852,000 | -1.9% | 5,874,831 | +3.7% | 0.01% | 0.0% |
| Q2 2021 | $540,285,000 | -19.4% | 5,666,337 | -3.8% | 0.01% | -27.8% |
| Q1 2021 | $670,576,000 | -14.3% | 5,889,465 | +4.2% | 0.02% | -21.7% |
| Q4 2020 | $782,184,000 | +77.6% | 5,650,385 | +5.5% | 0.02% | +53.3% |
| Q3 2020 | $440,360,000 | +9.6% | 5,357,835 | +4.3% | 0.02% | +7.1% |
| Q2 2020 | $401,915,000 | +82.1% | 5,138,257 | +3.4% | 0.01% | +55.6% |
| Q1 2020 | $220,765,000 | +6.5% | 4,968,839 | +2.4% | 0.01% | +28.6% |
| Q4 2019 | $207,278,000 | -4.5% | 4,853,159 | -4.3% | 0.01% | -12.5% |
| Q3 2019 | $217,020,000 | -31.7% | 5,072,925 | +1.3% | 0.01% | -33.3% |
| Q2 2019 | $317,874,000 | -6.4% | 5,005,872 | +2.3% | 0.01% | -7.7% |
| Q1 2019 | $339,432,000 | +87.6% | 4,893,771 | +17.6% | 0.01% | +62.5% |
| Q4 2018 | $180,954,000 | -41.5% | 4,161,780 | +2.7% | 0.01% | -33.3% |
| Q3 2018 | $309,332,000 | -1.3% | 4,052,023 | -0.6% | 0.01% | -7.7% |
| Q2 2018 | $313,265,000 | +55.7% | 4,075,248 | +3.3% | 0.01% | +44.4% |
| Q1 2018 | $201,208,000 | +37.0% | 3,946,033 | +24.6% | 0.01% | +50.0% |
| Q4 2017 | $146,861,000 | -12.2% | 3,166,465 | +0.8% | 0.01% | -25.0% |
| Q3 2017 | $167,291,000 | -14.0% | 3,141,018 | +0.3% | 0.01% | -20.0% |
| Q2 2017 | $194,421,000 | -4.2% | 3,130,273 | +4.5% | 0.01% | 0.0% |
| Q1 2017 | $202,997,000 | +1.9% | 2,994,938 | +5.7% | 0.01% | -9.1% |
| Q4 2016 | $199,211,000 | +5.5% | 2,833,316 | +6.4% | 0.01% | 0.0% |
| Q3 2016 | $188,889,000 | +49.1% | 2,662,660 | +2.8% | 0.01% | +37.5% |
| Q2 2016 | $126,664,000 | -19.0% | 2,589,718 | +4.9% | 0.01% | -20.0% |
| Q1 2016 | $156,294,000 | -41.8% | 2,468,719 | +3.1% | 0.01% | -44.4% |
| Q4 2015 | $268,512,000 | +31.6% | 2,393,587 | +13.0% | 0.02% | +125.0% |
| Q3 2015 | $203,993,000 | +14.6% | 2,118,090 | +21.8% | 0.01% | -33.3% |
| Q2 2015 | $178,079,000 | +79.8% | 1,739,224 | +9.0% | 0.01% | +71.4% |
| Q1 2015 | $99,047,000 | +72.4% | 1,595,226 | +21.8% | 0.01% | +75.0% |
| Q4 2014 | $57,450,000 | -7.0% | 1,309,252 | +20.0% | 0.00% | -20.0% |
| Q3 2014 | $61,748,000 | +404.0% | 1,090,962 | +299.7% | 0.01% | +400.0% |
| Q2 2014 | $12,251,000 | +17.2% | 272,913 | +27.6% | 0.00% | 0.0% |
| Q1 2014 | $10,457,000 | – | 213,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |